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SUMMARY PAGE 
THE PROBLEM 
Streptomycin sulfate was administered to eight selected squirrel monkeys i n  
sufficient dosage to cause suppression of  canal function as indicated by the threshold 
caloric test, emesis i n  the Slow Rotation Room (SRR), and ataxia. 
FINDINGS 
The clinical effects were maximal within a few days after the last injection of the 
drug. Recovery was very rapid at first then very gradual, requiring several months 
before stabilization of  a l l  of the clinical findings. 
The animals were sacrificed six or more months after the suppression at which time 
a l l  cl inical signs were normal again in five of the eight animals. The pathological 
changes were confined largely to the cristae and organ of  Corti, which were both in- 
volved i n  almost every case. Only very slight changes were observed i n  the maculae i n  
a few instances. lntraindividual difference in susceptibility to the toxic effects of 
streptomycin sulfate was shown by the number of courses of  the drug required and the ex- 
tent of pathological injury from approximately the same dosage. lntraindividual differ- 
ences with respect to the toxic effect on the three sensory organs (crista, macula, and 
organ o f  Corti) were great, and there were minimal differences between the effect on the 
cristae of  individual canals, and between the maculae o f  utricle and saccule. I t  was 
concluded that: 
1 .  
I 
2. 
3. 
4. 
The clinical tests used were not reliable indicators of  the pathophysiological 
state of the canal end organs but were fairly reliable indicators of  normal 
function of these organs. 
Streptomycin sulfate injures the hair cells of the organ o f  Corti as readily as 
those o f  the cristae, in squirrel monkeys. 
This drug has less predilection to the maculae and has a place i n  vestibular 
studies requiring selective suppression o f  canal function. 
With regard to emesis in the SRR and ataxia, the essentiality o f  normal function 
of  the semicircular canals has been demonstrated. No such essentiality was 
demonstrated for the otolith organs in the present investigation. 
Even the possibility that these findings have application to man i s  of  significance. 
Although relatively larger amounts of the drug must be administered to cause suppression 
of  canal function i n  the squirrel monkey, compared to man, there i s  a clear warning of 
the danger of injury to the organ o f  Corti. 
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I l l  
INTRODUCTION 
A systematic comparison between the responses of normal subjects and persons with 
bilateral loss of  labyrinthine function exposed to unusual force environments has demon- 
strated that the vestibular end organs are essential to the causation of typical symptoms 
o f  motion sickness (5,6,18,22). Even a partial loss o f  the vestibular function affords 
some protection, and among those so protected are patients who have received strepto- 
mycin sulfate for the treatment of  MQni&re's disease. Schuknecht (28) administered 
streptomycin sulfate to eight patients with MQnibre's disease i n  amounts just sufficient to 
result i n  unsteadiness. According to his investigation, no one suffered a loss i n  hearing, 
suggesting a selective affinity for the vestibular system. Ten years later, four of  his 
patients were re-examined; none experienced symptoms o f  motion sickness i n  the Slow 
Rotation Room and their hearing, when compared with the level before the treatment, 
had improved i n  three and was unchanged in one (7). These findings suggested the 
possibility that in man streptomycin sulfate might suppress the vestibular function in 
normal ears sufficiently to prevent motion sickness and preserve hearing with a good 
margin of safety. Moreover, i n  none of the reports describing the use of  this drug in the 
treatment of  MhiSre's disease (4,10,11,25) was there any mention of  severe impairment 
of  hearing. 
On the other hand, most pathological studies of  the ototoxic effect of  streptomycin 
sulfate i n  lower animals (1-3; 12-15;19,20,24-26;28,33-35) had revealed some hair cell 
loss i n  the cochlea as well as in the cristae of the semicircular canals i n  normal ears. 
Inasmuch as special differences were revealed, i t  seemed worthwhile to extend the 
studies to animals higher in the phylogenetic series, the better for extrapolation of the 
findings to man. What follows describes our results using squirrel monkeys, and i t  may 
be stated here that the implications to be drawn from the clinicopathological correlations 
reach far beyond their significance for motion sickness. 
PROCEDURE 
Eight healthy squirrel monkeys (Saimiri sciureus) were selected on the basis of 
normal semicircular canal function, as measured by the threshold caloric test (21) and 
susceptibility to vomiting i n  the Slow Rotation Room (SRR) (18,22). 
The threshold caloric test (TCT) was performed i n  a darkened room. The animal's 
head was secured and positioned so that the horizontal semicircular canals were i n  a 
vertical plane. The ear was irrigated with about 70 cc of  water i n  a period o f  forty 
seconds. Beginning with a temperature of 35.00 C, or lower, depending on previous 
results, the temperature of the water was dropped i n  successive tests until nystagmus was 
observed by electronystagmography, Frenzel goggles, and d i m  illumination. Hearing 
tests were not performed. 
In determining the susceptibility to emesis, the animal was exposed to rotation i n  
the SRR while free to move about in a small cage and under good illumination. Init ially, 
an attempt was made to obtain a "threshold angular velocity'' which led to emesis within 
1 
a period of  ten minutes. This often required so many trials that there was a risk of  
adaptation, and a single angular velocity of  10 RPM was used thereafter. Inasmuch as' 
the strength of the physical stimulus to the canals involved head rotations which were 
not experimenter paced, as well as angular velocity of the SRR, not much significance 
was attached to differences i n  the "duration" of exposure. Premonitory symptoms such 
as crouching, chewing, and especially retching were probable indications of  canal 
sickness; however, the sole criterion of positive canal sickness was emesis. 
An attempt was made to estimate the degree of ataxia i n  some instances (six out of 
eight). This was done by conditioning animals to walk a rod or wire; the procedures, 
however, were in the developmental stage and few quantitative data were obtained. 
The streptomycin sulfate was given i n  courses. Depending mainly on body weight, 
the init ial  course consisted of 16 to 23 doses of  50 mg each, given intramuscularly once 
daily. I f  at about the end of one month following the last dose, there was no sign of 
canal suppression, additional courses were given unti l the desired result was obtained; 
factors i n  addition to body weight sometimes influenced the number of  doses to begiven. 
The clinical tests were performed repeatedly, both during the administration o f  the drug 
and for a period of a t  least six months thereafter. 
Subsequently, the animals were sacrificed by means o f  intravital cardiac perfusion 
with Heidenhain-Susa fixative. The temporal bone block which included both inner 
ears was dissected out from the skull and immersed i n  the same fixative for a further 
period. After completing the fixation the bone was decalcified i n  5% trichloroacetic 
acid solution. The end point of decalcification was chemically detected with 5% 
ammonium oxalate and 5% ammonium hydroxide mixture. Dehydration was done i n  30%, 
50%, 70%, 80% (with iodine solution i n  it), 95%, 10Ph of ethyl alcohol, and ether- 
100% ethyl alcohol mixture ( 1 : l ) .  The specimen was processed to 3% celloidin (two 
weeks), 6% celloidin (two weeks), and 12% celloidin (three weeks). The celloidin 
hardening process was done very slowly. The bone was sectioned serially i n  a horizontal 
plane at 20 microns. One of each ten sections was stained in  Hematoxylin-Phloxine, 
mounted on glass slides and examined by l ight microscopy. 
The pathological findings of both vestibule and cochlea were portrayed using a 
graphic reconstruction technique (9,27). 
RESULTS 
CASE REPORTS 
Case E P  -- 
This animal received one course, total 1100 mg of the drug. Before medication, 
emesis occurred at SRR velocities of 3 and 4 RPM, TCT values were 34.9C R (right) and 
35.OoC L (left), and the animal could walk a 1/4" rod without diff iculty. Thirteen days 
after treatment began the TCT value was 34.0°C both ears, with a gradual fall to 
2 
velocity at 10 RPM; the animal was somewhat ataxic on walking and could not cross the 
1/4" rod. No further clinical tests were carried out unti l prior to sacrifice ten months 
following the medication, when the TCT value was 35.0° C both ears. There was no 
I 
Pathological studies revealed severe damage to the cristae, some hair cell loss in 
the basal turn of  the cochlea, but no evidence o f  injury to the maculae (Figures 1,2). 
The sensory epithelium of the summits of the cristae showed the severest pathological 
changes and hair cell loss of  any i n  the present series (Figure 3). 
The striking features of this case were: 1) the slow but eventual functional recovery, , 
except loss of  susceptibility to canal sickness, i n  the presence o f  severe loss of  hair cells 
i n  the cristae, and 2) the absence o f  hair cell loss i n  the maculae. 
Case FC - -
This animal received one course of the drug, 1150 mg. Before medication the TCT 
values were 33.3OC R and 33.00C L, and the animal could easily cross the 1/4" rod. 
Vomiting did not occur at  an SRR velocity of 5 RPM. The exposure at 10 RPM was not 
done. After 950 mg of  streptomycin, the TCT values were 33.OoC R and 33.4OC L, but 
one day after the last iniection the value was 28.4OC in  both ears. Thereafter, a rapid 
change occurred, and eight days following the last injection there was no response at an 
irrigating temperature o f  7%. Parallel to the fall i n  TCT values there was increasing 
ataxia, and, at time of complete suppression, the animal could not walk the 1/4" rod 
and crossed the 1/2" rod with difficulty. Clinical tests were not carried out between 
the 8th and 74th day after medication at which time the TCT value was 27% L, but 
there was no response (1 l 0C)  on the R. Three weeks later there was a response on the 
right at 10°C, and the animal could walk the 1/4" rod. Six months after medication 
the TCT values were 25.8OC R and 26.2OC L. Ten months after medication the TCT 
value was 35.0°C both ears, and the animal could walk the 27/1000" wire. Emesis 
did not occur at  10 RPM i n  the SRR. 
Pathological findings revealed moderate loss of  hair cells i n  the cristae and cochlea 
but none i n  the maculae. 
Noteworthy features of this case were: 1) the long (more than six months) recovery 
period following canal suppression, and 2) the absence of  any morphological damage in 
the maculae. 
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Figure 1 
Graphic portrayal of hair cell loss i n  inner ear end organs after 1100 mg of 
streptomycin sulfate. In the circles portraying the cristae, the horizontal l ine 
indicates the division between upper and lower half. (Case EP) 
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Figure 2 
Microphotograph showing the intact macula sacculi from the ear of  the 
animal which has received 1100 rng of streptomycin sulfate. (Case EP) 
840 x 
Figure 3 
Microphotograph showing a view of the severe end organ pathology in the 
crista of a horizontal semicircular canal. Note that the hair cell damage 
i s  more prominent on the summit of crista. (Case EP) 175 x 
Case ET --
This animal received three courses of the drug: 950 mg, 1050 mg, and 1000 mg, 
respectively. Prior to medication the TCT values were 33.70C R and 33.8OC L.  Emesis 
occurred at SRR velocity of  3 RPM, and the animal could readily cross the 1/4" rod. 
After one course o f  medication there was only slight canal suppression (31 . p C  R and 
31 .O°C L); emesis occurred at an SRR velocity of 7.5 RPM, and the animal fell once 
I - *  
~ 
I 
I 
, 
I (abnormal) while walking the 1/4" rod. 
The second course (1050 mg) was begun three months after completion of the first 
at which time the animal had apparently recovered, although the caloric test value 
revealed a slightly raised threshold. Following medication, the TCT values gradually 
decreased, and twenty days afterward were 25.2OC R and 27.OoC L. The animal failed 
to walk the 1/4" but could walk the 1" rod. Emesis, however, s t i l l  occurred at SRR 
velocities of  10 RPM. 
The third course (1000 mg) was begun three weeks after the second, and on the 
sixteenth day o f  medication the TCT temperatures had fallen to 3OoC R and 29.2OC L, 
but the animal could walk the 1/4" rod. On the first day after the completion o f  the 
course, there was no nystagmus response with an irrigating temperature of  1 l0C, and 
the monkey was grossly ataxic. Five days after the course there was no nystagmus 
response at loC-2OC, and this remained unchanged (l°C-?C both ears) even one 
month after the last injection. During this period, the monkey did not vomit i n  the SRR 
at 10 RPM and failed to,cross the 2 1/2" rod. Six months after the last course, the TCT 
values were 3O.pC R and 31 . P C  L. The animal could cross all but the 1/4" rod with- 
out difficulty, and emesis occurred at 10 RPM i n  the SRR. The clinical findings are 
summarized in  Figure 4. 
Pathological findings are summarized in Figure 5,  and i t  i s  seen that there was 
l i t t le  hair cell pathology i n  the cristae but moderate loss i n  the cochlea. The maculae 
were intact morphologically. 
'The interesting features i n  this case were: 1) the relatively slight loss of hair cells 
i n  the cristae after three courses of  streptomycin sulfate (3000 mg), yet complete sup- 
pression of canal function after completion o f  the third course, as indicated by the TCT; 
2) long suppressed period (for about one month); and 3) the relatively greater damage to 
the cochlea than to the cristae. 
Case ES --
This animal received three courses of the drug: 850 mg, 1000 mg, and 1150 mg. 
Prior to medication the TCT temperature was 34.5'C both ears, emesis occurred at 
5 RPM in the SRR, and there was no ataxia. During medication with 850 mg and for a 
month thereafter the maximum canal suppression as indicated by the TCT temperature 
was 33.5OC both ears. Ataxia did not appear and the animal vomited at 10 RPM in  the 
SRR. 
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Figure 4 
The course of caloric threshold and susceptibility to canal sickness i n  
another monkey after 3000 mg of  streptomycin sulfate (Case ET). White 
circles i n  the caloric test column indicate the testing points, white circles 
i n  the Slow Rotation Room column indicate the positive vomiting, and 
black dots with IN' and an arrow indicate no emesis at that level (10 RPM). 
White circles i n  ataxia test column indicate the normal rod-walking abil ity. 
White circles with diagonal lines indicate slight ataxia, and black dots 
indicate severe ataxia. The arabic numbers and rectangles below horizontal 
lines, with one month step abscissa, indicate the numbers of  streptomycin 
courses. 
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Graphic reconstruction demonstrating slight vestibular end organ pathology 
and moderate cochlear hair cell loss after 3000 rng of streptomycin sulfate. 
(Case ET) 
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The second course (1000 mg) was begun three months after completion of the f i rst  
one. There was only a slight further suppression during and for three weeks after medi- 
cation as indicated by the TCT (31 . P C  both ears). Third course was begun without 
further delay i n  the hope that there might be cumulative effects. 
During administration o f  ;he drug i n  the third course (1 150 mg) there was no 
evidence of canal suppression, and two days before completion the TCT temperature was 
31 .O°C both ears. Twelve da s after medication the TCT temperatures had fallen to al- 
most their lowest values (22.3 C R and 23.OoC L); the monkey did not vomit at 10 R P M  
i n  the SRR, but there was no definite evidence o f  ataxia. This was the only occasion 
the animal did not vomit out of a total of eight previous and five subsequent exposures. 
The TCT temperatures slowly rose; about one month later they were 25.OoC R and 26.0° 
C L; five months after medication the temperature was 35.0% both ears; the animal 
vomited in fifty-five seconds on exposure i n  the SRR and could walk the 27/1000" wire. 
Pathological findings revealed very slight hair cell pathology i n  the cristae (Figures 
6,7) but severe loss i n  the cochlea (Figures 8A and B). There was no evidence of damage 
i n  the maculae or spiral ganglion. 
Three things were demonstrated i n  this case: 1) the partial suppression of canal 
function sufficed to abolish canal sickness; 2) the cochlea may be far more susceptible 
to the ototoxic effects of  streptomycin sulfate than the cristae, a d  3) a shorter interval 
between courses may increase toxic effect. 
Case FN --
This monkey received three courses of  streptomycin sulfate: 1050 mg, 1150 mg, 
and 1150 mg, respectively. During and after the f i r s t  course, there was no definite 
change of canal sensitivity as indicated by TCT value, the animal vomited in the SRR, 
and there was no evidence of  ataxi.a. 
A second course (1 150 mg) was begun three months after completion o f  the first, 
again with no definite evidence of  canal suppression; so, a third course was begun 
nineteen days after completion of  the second. The TCT temperatures before this course 
(1 150 mg) were about 34.0°C R and 33.OoC L (strong). Two days before completion of 
the course the animal could walk the 1/411 rod. 
The first day after completion of  the third course (1 150 mg) gross ataxia appeared 
but the TCT temperatures were s t i l l  3O.pC R and 31.6OC L. %e fifth day afterward, 
the TCT temperature was 2.OoC L, and no response on the right with 2OC water irrigation. 
On the eleventh day TCT value was 2.80C both ears (Figure 9). At this time, emesis 
did not occur in the SRR at 10 RPM, and the monkey could barely cross the 2 1/2" rod 
with a shuffling and unsteady gait. The complete canal suppression was short-l ived . 
The TCT temperatures were 20.OOC R and 22.OoC L on the eighteenth day after the 
course, but vomiting did not occur i n  the SRR at  10 RPM, and the animal remained 
slightly ataxic. The rod-walking abil ity improved and the animal could cross the 1/4" 
rod with some difficulty on the twenty-fifth day. The TCT temperatures gradually rose 
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Figure 6 
Microphotograph showing very slight hair cell pathology in the horizontal 
semicircular canal crista after 3000 mg of streptomycin sulfate injection. 
(Case ES) 150 x 
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Graphic display showing slight canal end organ pathology after 3000 mg 
of streptomycin sulfate (Case ES). The cochlear pathology was severe. 
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Figure 8 A 
Microphotograph showing normal organ of Corti from upper middle and 
upper basal turns in a normal squirrel monkey. 185 x 
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Figure 88 
Microphotograph demonstrating the partial outer hair cell loss in upper 
middle turn, and the total loss of outer hair cells with some supporting 
cell destruction in the upper basal turn, after 3000 mg of streptomycin 
sulfate injection. (Case ES) 120 x 
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Figure 9 
The course of caloric threshold, susceptibility to emesis in Slow Rotation 
Room, and ataxia after 3350 mg of streptomycin sulfate (Case FN). The 
hair cell pathology in cristae was moderate, very slight in maculae, and 
moderate in cochlea with no spiral ganglion cell lesion. 
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and were 26.OO.C R and 27.OoC L on the 36th day; the animal vomited, for the first 
time after medication, on the 37th day. Six months after the last course the TCT value' 
was 35.OoC both ears, emesis occurred on rotation at 10 RPM, and the animal could 
walk the 27/1000" wire. 
~ 
Pathological study revealed moderate end organ pathology both i n  cristae and 
cochlea. The maculae were almost intact morphologically (Figure 10). 
The most striking features of this case were: 1) the init ial  appearance of gross 
ataxia at a time when the TCT value had decreased only slightly, and the disappearance 
o f  ataxia before there was a susceptibility to canal sickness; and 2) the possible cumu- 
lative toxic effect of the drug when a relatively short interval (nineteen days) separated 
two courses. 
Case DH --
This animal received four courses of the drug: 900 mg, 700 mg, 300 mg, and 900 
mg. Prior to the medication the TCT value was 34.0°C both ears, and the animal 
vomited at 3 RPM in  the SRR; ataxia tests were not carried out. During and after the 
first course of medication there was no change i n  susceptibility to canal sickness, and 
about three months later a second course was begun. 
The second course (700 mg) succeeded i n  suppressing canal function only slightly 
(28.5% R and 27.5OC L), and inasmuch as there was no change i n  susceptibility to 
canal sickness, a third course was begun about two months after completion of  the 
second . 
The third course (300 rrg) succeeded in  lowering (maximally) the TCT temperatures 
to 27.0% R and 26.4OC L on the eighth day after treatment, but the animal did not 
lose i t s  susceptibility to canal sickness at 10 RPM and could walk the 1/4" rod without 
difficulty. The last TCT was carried out two months after the last injection and was 
29.8OC both ears. 
The fourth course (900 mg) began about four months after completion of  the third, 
and after two weeks the TCT temperatures were 27.8OC R and 18.0% L, and the 
animal was ataxic but vomited at 10 RPM in  the SRR. On the last day of medication 
the TCT tem erature was 24.4OC both ears and thereafter gradually fell to its lowest 
level, 20.0 C both ears, on the twenty-fourth day post-medication. At  this time the 
animal was ataxic, crossed the 1/4" rod with difficulty, and did not vomit at 10 RPM 
in  the SRR. Thirty days post-medication there was a significant increase i n  the TCT 
temperature on the right (26.OoC) but only a slight increase on the left  (21.4OC); the 
animal was s t i l l  ataxic and did not vomit in the SRR. Thereafter, there was a gradual 
loss of the ataxia, and six months post-medication the animal could cross the 27/1000" 
wire, the TCT temperature was 32.OoC both ears, but susceptibility to canal sickness 
had not returned . 
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Graphic reconstruction showing moderate pathology both in cristae and 
in organ of Corti after 3350 mg of streptomycin iniection. (Case FN) 
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The hair cell loss was moderate in the cristae, slight in the maculae (Figure 11); 
however, both the organ of  Corti and spiral ganglion were almost completely destroyed 
(Figure 12). 
The noteworthy features i n  this case were: 1) the large amount of the drug which 
was enough to greatly damage the cochlea that was needed to suppress canal function, 
and 2) the comparative effects on ataxia and susceptibility to canal sickness. 
Case DR -- 
This animal received four courses of  streptomycin sulfate: 900 mg, 1150 mg, 
900 mg, and 1100 mg. Prior to administration o f  the drug the TCT temperature was 
34.00C both ears, and emesis was observed at 5 RPM i n  the SRR. Both during and after 
the first course the animal vomited in the SRR, and three months afterward the second 
course was begun. 
In the second course (1 150 mg) the TCT temperature fell to 29.9OC both ears nine 
days after the last injection, but ataxia was not observed, and the animal vomited i n  
the SRR. 
The third course (900 mg) was begun f i f ty days after completion of  the second. 
Shortly before this time the TCT temperatures were 32.3OC R and 32.8% L; the animal 
was not ataxic and vomited i n  the SRR. During and after this course, the animal was 
not ataxic and continued to vomit i n  the SRR; the lowest TCT temperatures were 28.2OC 
R and 27.5OC L recorded on the eighteenth day post-medication. 
The fourth course (1100 mg) was begun 3 1/2 months after the third, at which time 
the TCT temperature was 29.@C both ears. The maximum canal suppression occurred 
between the 5th and 12th days after the last injection, and the TCT temperature (both 
ears) was about 24.OoC; during this period the animal did not vomit at  10 RPM in the 
SRR. Fifteen days after the course the TCT temperatures were 3O.O0C R and 28.OoC L; 
the animal vomited in the SRR and could walk the 1/4" rod without diff iculty. The 36th 
day after completion of  the fourth course the TCT temperatures were 31.8OC R and 
32.OoC L. The animal was not tested again till prior to sacrifice seven months later at  
which time the TCT temperature was 35.OoC both ears. The animal could cross the 
27/1000" wire and became sick at  10 RPM i n  the SRR. 
Pathological studies revealed slight pathology both in cristae and maculae, and 
moderate pathology in cochlea (Figure 13). The low magnification view o f  the entire 
cochlea clearly demonstrates the different degrees of pathology i n  each turn (Figure 14). 
This case seemed to establish the fact that a long period o f  time was required to 
restore the normal TCT values. The canal sickness was not abolished unti l the TCT 
temperatures, shortly after medication, fell below 27.00C to 28.@C. 
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Figure 1 1  
Microphotograph showing the saccular macula with a slight change after 
2800 mg of streptomycin sulfate (Case DH). Hair cell population i s  
normal. 840 x 
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Figure 12 
Spiral display and bar grams demonstrating the severest destruction of 
cochlear hair cells and spiral ganglion cells after 2800 mg of streptomycin 
sulfate injection, in the present series of monkeys (Case DH). The hair 
cell pathology i n  cristae was also moderate. The caloric threshold was 
suppressed as low as 2OoC, and recovered. This animal did not show any 
recovery i n  canal sickness susceptibility with emesis when tested, however. 
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Figure 13 
Graphic reconstruction showing very slight vestibular end organ pathology, 
after 4050 mg of streptomycin sulfate (Case DR). The highest caloric threshold 
obtained was 24OC. Both organ of Corti and spiral ganglion had moderate 
pa tho1 ogy . 
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Figure 14 
Microphotograph demonstrating the entire cochlea, with the moderate 
pathology i n  organ of  Corti and spiral ganglion, after 4050 mg of streptomycin 
sulfate injection (Case DR). Notice the loss of primary neurons i n  osseous 
spiral lamina in  the basal turns. Organ of  Corti and spiral ganglion are 
morphologically intact in  middle and apical turns. 30 x 
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Case DM --
This animal received five courses of streptomycin sulfate: 800 mg, 800 mg, 800 mg, 
1000 mg, and 1200 mg (total 4600 mg). Prior to medication the TCT temperature was 
34.PC both ears, and emesis occurred at 3 RPM in the SRR. The first four courses 
neither abolished susceptibility to canal sickness nor caused ataxia; the lowest TCT 
temperature was recorded shortly after completion of  the fourth course and was about 
31 . P C  both ears. 
The fifth course (1200 mg) was begun three weeks after completion of  the fourth at 
which time the TCT temperature was about 31 .O°C both ears. On the second day after 
the last injection the TCT temperatures were 24.PC R and 27.OoC L, and the animal 
was slightly ataxic and failed to vomit i n  the SRR. Complete suppression occurred be- 
tween the second and eighth day when there was no response at a temperature of  3% 
(Figure 15). Fifteen days after medication the TCT temperatures were 2O.O0C R and 
23.4OC L, and the animal was s t i l l  ataxic and did not vomit i n  the SRR. Twenty days 
afterward the TCT temperatures were 23.OoC R and 24.8OC L, and when tested the 
following day, the animal could walk the 1/4" rod without diff iculty and became sick 
at 10 RPM in the SRR. Six months after completion of the fifth course the TCT value 
was 35.OoC both ears, emesis occurred at  10 RPM i n  the SRR, and the animal could 
wai k the 27/1000" wire. 
Pathological studies revealed almost intact end organs i n  cristae (Figure 16A and 
B) and maculae. On the contrary, the cochlea showed moderate hair cell pathology 
(Figure 17). 
The most interesting new features of this case were: 1) the minimal pathological 
changes i n  the cristae despite complete suppression as indicated by the caloric test, 
ataxia test, and SRR test shortly after the fifth course of  medication, and 2) comparison 
with Case DH which showed moderate to severe pathology i n  the cristae and cochlea. 
D I SCUSSl 0 N 
In discussing the clinicopathological correlations a distinction wi l l  be made be- 
tween the findings at the time of  sacrifice which have high validity and those in the 
antecedent experimental period when the pathological changes could be established 
only by inference. A summary of the results (Figure 18) has been prepared as an aid in 
this discussion. 
FINDINGS AT TIME OF SACRl FlCE 
With regard to the vestibular organs the pathological alterations were largely con- - 
fined to the cristae, and 
Although our findings do 
that the explanation lies 
One difference has been 
here the damage was greater on the summit than on the sides. 
not directly bear on this problem, i t  i s  tempting to speculate 
i n  mechanostructural differences between summit and slopes. 
emphasized by Nomura - -  et al. (23) who demonstrated that the 
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Figure 15 
The course of caloric threshold change, ataxia, and canal sickness 
susceptibility change. The monkey had very slight crista lesions with 
moderate damage in organ of Corti, after 4600 mg of  streptomycin sulfate. 
(Case DM) 
I 
16A - 1 2 0 ~  16B - 130 x 
Figure 16A & B 
Microphotographs show morphological I y normal horizontal canal 
'A' i s  from a normal ear of a squirrel monkey. 'B' i s  from a mon 
received 4600 mg of streptomycin sulfate. (Case DM) 
cristae. 
Ley whic 1 
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Figure 17 
Graphic display showing very slight pathology in crista, even after 
4600 mg of streptomycin sulfate (Case DM). The caloric nystagmus was 
once negative at 2OC. The cochlea demonstrates moderate hair cell 
pathology. 
Figure 18 
Clinical and pathological findings i n  eight squirrel monkeys after streptomycin 
sulfate iniection. 
Clinical findings: 
CT : Caloric threshold (OC) 
Al l  numbers, except Maximum Suppression column, are averages o f  
both ears, and also of  some trials. 
: Susceptibility to canal sickness i n  SRR 
S : Positive canal sickness (vomiting) 
N : Negative canal sickness (no vomiting) 
: Dynamic equilibrium as measured by walking abil ity on rods 
(Ataxia test) 
f+t. : Severe ataxia 
: Moderate ataxia 
+ : Slight ataxia - : No ataxia (Normal) 
SRR 
ATX 
Pathological findings: 
* : Severe 
ft : Moderate 
+ : Slight 
2 : Very slight - : None 
A l l  symbols indicate the estimated averages of pathology i n  both 
ears from each individual animal. 
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efferent vestibular fibers ended i n  the slopes and not i n  the summits o f  the cristae in . 
guinea pigs. It i s  explained i n  part at least by the findings of Wersdll and Hawkins 
(31) who found that type 1 hair cells which were more commonly located on the summit 
(30) were more easily damaged than type 2 by chronic streptomycin intoxication in cats. 
The degree o f  damage to the cristae varied from very slight to severe and had no 
relation to the number of courses of  the drug given, indicating great individual variance 
i n  predilection o f  the toxic effect among the three canals; this has special significance 
when correlating the findings with the threshold caloric test which involved primarily 
the horizontal canals. 
The clinical findings at time o f  sacrifice were essentially unchanged when compared 
with values obtained prior to the administration of  the drug in five of the eight monkeys 
i n  which the pathological changes i n  the cristae varied from very slight to moderate. 
Among the remaining three, EP no longer manifested canal sickness although the caloric 
test revealed a normal threshold value; ET had a slightly raised (3.1OC) caloric thresh- 
old, manifested slight ataxia, but susceptibility to canal sickness had returned; DH had 
a slightly raised caloric threshold (2.@C), was not susceptible to canal sickness, but 
did not manifest ataxia. 
The possible implications o f  these findings for man are important. I f  they hold 
true, then the threshold caloric test i s  not necessarily reliable as an indicator of  normal 
morphology of the cristae, although quite reliable as an indicator of normal function i n  
terms of  susceptibility to canal sickness and ataxia. 
With regard to the maculae none of the abnormal clinical findings at time of  
sacrifice could reasonably be ascribed to these organs. The pathological alterations 
noted i n  the maculae were very slight i n  four instances: three i n  the saccular maculae 
and only one in the utricular macula. Among the latter only DH manifested clinical 
abnormalities; the raised threshold to caloric stimulation was surely referable to the 
canals, and the loss of  susceptibility to emesis i n  the SRR almost certainly was of the 
same origin. 
This relative freedom from injury i n  the maculae was striking and suggests that, 
with judicious use, streptomycin SUI fate combined with subsequent pathological confir- 
mation has an important place i n  carrying out functional vestibular experiments i n  
squirrel monkeys. 
Pathological changes were found i n  the organ of  Corti i n  al l  eight monkeys and i n  
four of  these there were also alterations i n  the spiral ganglion. There were very mini- 
mal pathological changes i n  the stria vascularis i n  a few instances. These findings are 
similar to those reported by McGee and Olszewski (20) on cats which received strepto- 
mycin sulfate (50-200 mg/kg daily, total 1800-5600 mg); pathological studies revealed 
cochlear alterations i n  three of seven animals and in two of  these three, spiral ganglion 
cell lesions also were present. 
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. Our findings, insofar as they are extrapolable to man, interdict the use o f  strepto- 
mycin sulfate for the prevention of motion sickness. In the case of  EP where the predi- 
lection for injury to the cristae was greatest and for the organ of  Corti least, the 
possibility existed that a smaller dose of the drug might have had the desired effect 
without injuring the cochlea. At  the other extreme, DM required five courses of 
medication which resulted i n  only very slight damage to the cristae but moderately 
severe damage to the organ of Corti. 
. 
FINDINGS PRIOR TO SACRIFICE 
In view of the findings just described, the question must be raised whether patho- 
logical changes existed at  the time the animals were originally selected for experimen- 
tation. This possibility cannot be discounted although eleven other animals with normal 
caloric thresholds and high susceptibility to canal sickness have been sacrificed, and 
none revealed "spontaneous" pathological changes i n  the vestibular organs (8). More- 
over, in the present series not only was an ototoxic drug administered to the point of  
canal suppression but also three of the eight had functional abnormalities at time of  
sacrifice. 
The most striking features i n  this period under discussion are: 1) the individual 
variance i n  susceptibility to the toxic effects of streptomycin sulfate and 2) the time- 
course of the clinical changes. There was a small margin between the fatal dose and 
the amount of  the drug necessary to suppress canal function; a number of  monkeys re- 
ceiving slightly larger daily doses than those used in  this series did not survive. This 
led to the administration of  the drug in courses. Here i t  was learned that i n  order to 
ensure a cumulative effect, the second course had to be instituted within a short time, 
preferably not delayed longer than two weeks, following completion of  the preceding 
course. It would appear that the squirrel monkey i s  far less susceptible to the vestibulo- 
toxic effects of  streptomycin sulfate than man. 
With regard to the clinical indications o f  the ototoxic effects, there was much 
similarity i n  terms of the appearance and subsequent disappearance o f  these abnormal 
signs. This  was not surprising inasmuch as these effects had their genesis largely i f  not 
entirely i n  the semicircular canals. The clinical effects were never prominent until 
nearly al l  of the drug had been administered, and the maximum effects were usually 
noted within a few days after the last injection. A slight increase i n  the caloric thresh- 
old was usually noted first, then a further increase accompanied by ataxia and loss 
o f  susceptibility to canal sickness. 
At  the t ime of  maximum suppression nystagmus was not obtained on irrigation with 
cold water i n  five instances, and the threshold temperatures were 2OoC to 24OC i n  the 
other three. At the latter levels susceptibility to canal sickness was lost, but ataxia 
was not present i n  one, slight i n  one, and not tested in one other. 
Recovery could be divided into an early period when i t  was relatively rapid and a 
late period when i t  was extremely slow. Usually, there was evidence of  rapid recovery 
2? 
I 
within a few days after maximum suppression had occurred, and this was followed by . 
slow improvement measured in  months. Ataxia tended to disappear before susceptibility 
to canal sickness returned, and the final stabilization of the caloric threshold took place 
last. 
Recovery probably involved two mechanisms, namely, reversibil i ty of  iniurious 
effects of the drug and a central compensatory phenomenon. In  two cases there was no 
nystagmic response to cold water at the time of maximum suppression, yet, the post- 
mortem findings revealed minimal pathological changes in  the cristae of the horizontal 
canals. This strongly suggests a reversible injury had taken place. This i s  supported 
also by the fact that the maximum suppression lasted only a matter of days. In  this 
connection i t  i s  worth noting that Wersill and Flock (32) reported that the reduction of 
microphonic output from the lateral line organ of toleost fish, after applying low con- 
centrations of streptomycin sulfate, was of a reversible nature. 
That compensation at the higher nervous system level occurred i s  suggested by the 
extremely long, late phase of  the recovery period. In the case of  EP, the caloric 
thresholds were far above normal baseline values four months, and in  the case of FC six 
months, after the last injection of the drug. It usually requires a longer period to com- 
pensate the balancing activity after the surgical canal ablation than after the macular 
destruction (17). 
The original purpose of this investigation was served in  demonstrating that strepto- 
mycin sulfate has a high predilection for the cochlea i n  squirrel monkeys as well as the 
cristae, thus reducing the likelihood that i t  can be used in  man without danger to hear- 
ing (16,29). This does not eliminate the possibility, however, inasmuch as Schuknecht's 
findings i n  unilateral Mknikre's patients continue to point to the possibility that amounts 
of  this drug sufficient to suppress the diseased canal function may be administered with- 
out loss of hearing i n  normal ears over a period of ten years (7). 
The findings i n  this study emphasize that 1 )  following injury to the canal end organs, 
more than six months may be required before the subsequent pathological and functional 
compensations have been established, and 2) a return to normal values of  the threshold 
caloric test does not necessarily indicate normal end organ morphology. I t  would be 
highly desirable to determine i f  this holds true for man. 
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3. A B S T R A C T  
Streptomycin sulfate was injected to eight selected squirrel monkeys in 
sufficient dosage to cause suppression of canal function as indicated by the threshold caloric 
test, emesis i n  the Slow Rotation Room, and ataxia. The animals were sacrificed six months 
after the suppression and slides for light-microscopic investigation were prepared following the 
standard temporal bone preparation procedure. Pathological findings were confined largely to 
the cristae and organ of Corti, which were both involved in  almost every case. Only very 
slight changes were observed in  the maculae in a few instances; therefore, this drug has a 
place i n  vestibular studies requiring selective suppression of canal function. The clinical tests 
used were not reliable indicators of the pathophysiological state of the cristae but were fairly 
reliable indicators of  normal function of these organs. Wi th regard to emesis in the SRR and 
ataxia, the essentiality of normal function of the semicircular canals has been demonstrated. 
No such essentiality was demonstrated for the otolith organs i n  the present investigation. 
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